Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Diabetologist
M.B.B.S, Dip. In Diabetes
Family Physician
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS (Pb), MRCP (UK), FRCP (Glasgow), FRCP (Ireland), FRCP (London), FRCP (Edin), Ph.D (WA), Post Doc (Oxford)
Internal Medicine Specialist
MBBS (Pb), MRCP (UK), FRCP (Glasgow), FRCP (Ireland), FRCP (London), FRCP (Edin), Ph.D (WA), Post Doc (Oxford)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
Certified in Diabetology (USA), F.C.P.S (Medicine), M.B.B.S
Internal Medicine Specialist
Certified in Diabetology (USA), F.C.P.S (Medicine), M.B.B.S
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Gastroenterologist
MBBS, MACG (USA), MD (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures